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Associations Between Concentrations of
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OBJECTIVE—Our objective was to examine the associations between concentrations of vi-
tamin D and concentrations of insulin, glucose, and HbA1c in a nationally representative sample
of adolescents in the U.S.
RESEARCH DESIGN AND METHODS—We used data for 1,941 adolescents, aged
12–17 years, who participated in the National Health and Nutrition Examination Survey be-
tween 2001 and 2006.
RESULTS—Adjusted concentrations of insulin were ~24% lower among male subjects with a
concentration of vitamin D $75 nmol/L than among male subjects with a concentration of
vitamin D,50 nmol/L (P = 0.003). Concentrations of vitamin D were inversely associated with
concentrations of glucose only among Mexican American male subjects (P = 0.007). No signif-
icant associations between concentrations of vitamin D and HbA1c were detected.
CONCLUSIONS—Our results support an inverse association between concentrations of
vitamin D and insulin primarily in adolescent male subjects.
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In recent years, the relationships be-tween vitamin D and factors involvedin glucose homeostasis have received a
great deal of attention. Few studies have
been conducted using pediatric samples
(1–3). Because the prevalence of deficient
or insufficient vitamin D status is high
among children and adolescents in the
U.S. and is possibly increasing (4,5), any
deleterious effect of suboptimal vitamin D
status on glucose homeostasis is of in-
terest, especially in light of concerns
about increases in diabetes among youth
in the U.S. (6). Most previous studies have
used small, selected samples of adoles-
cents. To provide additional insights
into the associations between circulating
concentrations of vitamin D and con-
centrations of insulin and glucose, we ex-
amined data from a large, representative
sample of adolescents that included
African Americans and Mexican Ameri-
cans in the U.S.
RESEARCH DESIGN AND
METHODS—We used data from the
National Health and Nutrition Examina-
tion Survey (NHANES) 2001–2006 (7).
The participants were recruited using a
multistage, stratified sampling design,
which is an efficient approach to obtain-
ing a sample representative of the civilian
noninstitutionalized population. The par-
ticipants were interviewed at home and
were invited to attend a mobile examina-
tion center, where they were asked to com-
plete additional questionnaires, to undergo
various examinations, and to provide a
blood sample. The study received ap-
proval from the NHANES Institutional
Review Board, and participants were
asked to sign an informed consent form.
Details about the survey can be found else-
where (7).
Serum concentrations of vitamin D
(25-hydroxyvitamin D) were measured
using the Diasorin 25-OH-vitamin D
assay (Diasorin, Stillwater, MN), a radio-
immunoassay (8). We created three cate-
gories of vitamin D concentrations:
deficiency, ,50 nmol/L; insufficiency,
50 to ,75 nmol/L; and sufficiency, $75
nmol/L (9). Themethods used tomeasure
insulin (a Pharmacia insulin radioimmu-
noassay kit, a Tosoh AIA-PACK IRI, and a
Merocodia insulin enzyme-linked immu-
nosorbent assay), glucose (a Cobas Mira
chemistry system and a Roche/Hitachi
911 analyzer), and HbA1c (Primus auto-
mated high-performance liquid chroma-
tography models CLC330 and CLC385
and an HbA1c 2.2 Plus glycohemoglobin
analyzer) are described elsewhere (7).
Covariates included age, sex, race, or
ethnicity (white, African American, Mex-
ican American, other Hispanic, or mixed
race), leisure-time physical activity, BMI
percentiles, supplement use during the
pastmonths (yes or no), concentrations of
HDL cholesterol and non-HDL choles-
terol, and a 6-month sampling period. To
estimate physical activity, we calculated
an average daily metabolic equivalent task
hours index. BMI percentiles were calcu-
lated from measured weight and height
using the Centers for Disease Control and
Prevention’s growth charts.
We limited our analyses to partici-
pants aged 12–17 years who attended the
morning examination and who had fasted
at least 8 h.We excluded participants who
had been diagnosed with diabetes. Ad-
justed mean concentrations of insulin (af-
ter log transformation), glucose, and
HbA1c were calculated using ANCOVA.
The statistical significance of the tests for
linear trend of means conducted by using
general linear contrasts was assessed with
an adjusted Wald F statistic that adjusts
for the denominator degrees of freedom.
The statistical software SUDAAN was
used for the analyses to account for the
multistage, stratified sampling design.
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RESULTS—During the 6-year study
period, 2,070 adolescents, aged 12–17
years, attended the morning examination
of themobile examination center. Data for
concentrations of glucose, insulin, and
vitamin D were available for 2,028 sub-
jects. After excluding records with miss-
ing data for covariates, the final analytic
sample comprised 1,941 participants, in-
cluding 531whites, 620AfricanAmericans,
632 Mexican Americans, and 158 partici-
pants of another race or ethnicity.
The means were 65.9 pmol/L (geomet-
ric mean: 50.3 pmol/L), 5.1 mmol/L, 5.2%,
and 59 nmol/L for concentrations of
Table 1—Unadjusted and adjusted geometric means for concentrations of insulin and means for glucose and HbA1c by levels of




Vitamin D adjusted for
sampling period (nmol/L)
Vitamin D adjusted for multiple
covariates (nmol/L)*
,50 50 to ,75 $75 P† ,50 50 to ,75 $75 P† ,50 50 to ,75 $75 P†
Insulin (pmol/L)
Total 1,941 60.1 50.4 44.7 ,0.001 60.3 50.4 44.5 ,0.001 56.3 51.2 47.7 0.004
Male subjects 1,000 60.4 48.2 40.7 ,0.001 60.3 48.2 40.7 ,0.001 56.7 48.5 43.3 0.003
Female subjects 941 59.8 53.0 50.8 0.040 60.3 52.8 50.2 0.021 55.7 54.4 54.7 0.818
White subjects 531 57.5 51.8 44.7 0.013 57.6 51.8 44.7 0.012 52.8 51.5 47.4 0.172
African American subjects 620 59.7 46.1 43.3 0.053 60.1 45.3 42.8 0.033 57.4 51.7 48.1 0.080
Mexican American subjects 632 68.4 51.3 44.9 ,0.001 68.0 51.5 45.4 ,0.001 62.8 54.0 52.3 0.008
Male subjects
White 268 72.5 50.2 40.7 0.001 71.8 50.1 41.0 0.001 58.8 50.2 44.6 0.043
African American 343 50.2 40.2 37.7 0.075 50.4 39.9 37.3 0.053 48.2 44.5 37.4 0.033
Mexican American 313 67.7 49.2 40.3 ,0.001 67.4 49.3 40.6 ,0.001 60.9 51.5 46.3 0.005
Female subjects
White 263 48.3 53.5 50.5 0.701 48.5 53.6 50.1 0.776 46.9 53.0 52.7 0.236
African American 277 69.3 57.3 78.6 0.773 69.7 55.9 77.1 0.808 68.9 58.6 78.4 0.677
Mexican American 319 69.1 54.2 58.9 0.301 68.5 54.7 60.1 0.349 65.5 57.5 63.3 0.726
Glucose (mmol/L)
Total 1,941 5.1 5.1 5.1 0.469 5.1 5.1 5.1 0.806 5.1 5.1 5.1 0.457
Male subjects 1,000 5.2 5.2 5.2 0.847 5.2 5.2 5.2 0.993 5.2 5.2 5.2 0.710
Female subjects 941 4.9 5.0 4.9 0.862 5.0 5.0 4.9 0.503 5.0 5.0 4.9 0.401
White subjects 531 5.1 5.1 5.1 0.812 5.1 5.1 5.1 0.982 5.1 5.1 5.1 0.728
African American subjects 620 5.0 4.9 4.9 0.397 5.0 4.9 4.9 0.321 5.0 4.9 4.8 0.095
Mexican American subjects 632 5.2 5.1 5.1 0.119 5.2 5.1 5.1 0.072 5.2 5.1 5.0 0.012
Male subjects
White 268 5.3 5.2 5.2 0.916 5.3 5.2 5.2 0.841 5.2 5.2 5.2 0.973
African American 343 5.1 5.0 4.9 0.072 5.1 5.0 4.9 0.071 5.1 5.0 4.9 0.098
Mexican American 313 5.4 5.2 5.2 0.009 5.4 5.2 5.2 0.003 5.4 5.2 5.2 0.007
Female subjects
White 263 4.9 5.0 4.9 0.730 5.0 5.0 4.9 0.591 5.0 5.0 4.9 0.584
African American 277 4.9 4.8 4.8 0.907 4.9 4.8 4.8 0.789 4.9 4.8 4.8 0.706
Mexican American 319 5.1 5.0 4.9 0.150 5.1 5.0 4.9 0.159 5.1 5.0 4.9 0.258
HbA1c (%)
Total 1,941 5.2 5.2 5.2 0.471 5.2 5.2 5.2 0.286 5.2 5.2 5.2 0.626
Male subjects 1,000 5.2 5.2 5.2 0.803 5.2 5.2 5.2 1.000 5.2 5.2 5.2 0.187
Female subjects 941 5.2 5.2 5.1 0.227 5.2 5.1 5.1 0.086 5.2 5.2 5.2 0.694
White subjects 531 5.1 5.2 5.2 0.282 5.1 5.2 5.2 0.364 5.1 5.2 5.2 0.487
African American subjects 620 5.3 5.3 5.2 0.578 5.3 5.3 5.2 0.552 5.3 5.3 5.2 0.427
Mexican American subjects 632 5.2 5.2 5.2 0.562 5.2 5.2 5.2 0.832 5.2 5.2 5.2 0.621
Male subjects
White 268 5.1 5.2 5.2 0.287 5.1 5.2 5.2 0.208 5.1 5.2 5.2 0.182
African American 343 5.3 5.3 5.2 0.587 5.3 5.3 5.2 0.575 5.3 5.4 5.2 0.596
Mexican American 313 5.2 5.2 5.2 0.815 5.2 5.2 5.2 0.676 5.2 5.2 5.2 0.600
Female subjects
White 263 5.1 5.1 5.1 0.906 5.1 5.2 5.1 0.910 5.1 5.1 5.1 0.899
African American 277 5.3 5.2 5.1 0.493 5.3 5.2 5.1 0.443 5.3 5.2 5.1 0.298
Mexican American 319 5.1 5.2 5.1 0.891 5.1 5.2 5.1 0.905 5.1 5.2 5.2 0.851
*Adjusted for age; sex; race, or ethnicity; leisure-time physical activity; 30-day use of vitamins, minerals, or other dietary supplements; BMI percentile; HDL cho-
lesterol; non-HDL cholesterol; and examination period. Examination period was a dichotomous variable representing the two 6-month periods of 1 November
through 30 April and 1 May through 31 October. †P value for adjusted Wald F test for linear contrast.
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insulin, glucose, HbA1c, and vitamin D,
respectively. Furthermore, 31.5 6 2.1%
(means6 SE;male subjects 27.4%, female
subjects 35.7%) had a concentration of
vitamin D ,50 nmol/L, 48.3 6 2.0%
(male subjects 49.8%, female subjects
46.6%) had a concentration 50 to ,75
nmol/L, and 20.36 1.6% (male subjects
22.7%, female subjects 17.7%) had a con-
centration $75 nmol/L.
Adjusted concentrations of insulin
were approximately 24% lower among
male subjects with a concentration of
vitamin D $75 nmol/L than among male
subjects with a concentration of vitamin
D,50 nmol/L (P = 0.003) (Table 1). Con-
centrations of vitamin D were inversely as-
sociated with concentrations of glucose
among Mexican American male subjects
(P = 0.007). No significant associations be-
tween concentrations of vitamin D and
HbA1c were detected.
CONCLUSIONS—After adjusting for
covariates, we found significant inverse
associations between concentrations of
vitamin D and insulin among adolescent
male subjects but not female subjects.
Several previous reports have noted in-
verse relationships between concentrations
of vitamin D and surrogate measures of
insulin resistance in samples of obese
adolescents (1,2) and in a population-
based sample of children and adolescents
(3). Studies in animals and humans suggest
that vitamin D status affects insulin secre-
tion (10), vitamin D receptor expression
(11), and tyrosine phosphorylation of in-
sulin receptor substrate 1 (12).
The large, nationally representative
sample of adolescents represents an im-
portant strength of our study. Several
limitations deserve to be acknowledged.
The cross-sectional study design pre-
cludes establishing causality. The possi-
ble effect of the use of different methods
to measure concentrations of insulin,
glucose, and HbA1c during the various
survey cycles on our results is unclear.
Concern has been expressed about possi-
ble assay variability for the vitamin D as-
say in the NHANES (13). However, the
apparent impact on vitamin D parameters
for the period of 2000–2004 was small
(14). We were unable to adjust for Tanner
stage because this information was not
collected.
Prospective studies and clinical trials
are needed to clarify the relationships
between concentrations of vitamin D
and factors involved in glucose homeo-
stasis. Studies using gold-standard tech-
niques to assess insulin resistance also
would yield valuable insights. The possi-
bility that vitamin D may affect insulin
resistance has potential implications for
testing vitamin D concentrations in chil-
dren and adolescents; recommendations
regarding the use of vitamin D supple-
ments and sun exposure, especially in
populations at risk for insulin resistance;
and fortification of foods. The prevalence
of vitamin D deficiency and insufficiency
is substantial among adolescents in the
U.S.; ~2% of adolescents had concentra-
tions of vitamin D,27 nmol/L, 14% had
concentrations ,50 nmol/L, and 33%
had a concentration $75 nmol/L during
2001–2004 (4,5).
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